Form 4: Immatics Director Acquires Stock Options

Immatics N.V. director Peter Alan Chambre acquired 48,000 stock options with an exercise price of $9.09, vesting on June 16, 2026.

Summary

• Peter Alan Chambre, a Director at Immatics N.V., acquired 48,000 stock options.
• The options have an exercise price of $9.09 per share.
• These options are exercisable starting June 15, 2036.
• The options vest 100% on the first anniversary of the grant date, which is June 16, 2026.
• The transaction was reported on June 18, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard stock option grant to a director, indicating long-term alignment, but without immediate financial impact or significant new information.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The exercise price of $9.09 suggests a potential upside if the stock price increases significantly above this level.

Negatives

• The options are not exercisable until June 15, 2036, which is a long vesting period.
• The full vesting date is June 16, 2026, meaning the options are not immediately available for exercise.

Risks

• The value of the stock options is entirely dependent on the future stock price of Immatics N.V.
• If the stock price does not exceed the exercise price of $9.09 by the vesting and exercise dates, the options will expire worthless.

Future Outlook

The acquisition of stock options by a director suggests a positive outlook on the company's future stock performance, contingent on the stock price exceeding the exercise price by the vesting and exercise dates.

Industry Context

StockSavvy.ai notes that insider option grants are common in the biotechnology and pharmaceutical sectors, often used as long-term incentives. The specific terms of this grant, including the exercise price and vesting schedule, will be critical in determining its ultimate value and signaling effect.

Stakeholder Impact

• Shareholders: The grant of options to a director can be seen as a positive alignment of interests, potentially leading to increased focus on long-term shareholder value. However, it also represents potential future dilution if exercised.
• Employees: This filing does not directly impact employees, but it reflects the company's compensation strategy for its leadership.
• Management: The director receiving the options is incentivized to perform well and increase the company's stock price.

Next Steps

• The stock options will vest on June 16, 2026.
• The stock options will become exercisable from June 15, 2036.

Key Dates

Keywords

Immatics N.V., IMTX, Form 4, Stock Options, Director, Beneficial Ownership, SEC Filing, Insider Trading